NCT06654791View on ClinicalTrials.gov

Mass Balance Clinical Trial of SIM0270

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

October 17, 2024

Primary Completion Date

March 31, 2025

Study Completion Date

March 31, 2025

Conditions
Healthy Participants
Interventions
DRUG

[14C] SIM0270 Oral Preparation

Use according to the prescribed protocol

Trial Locations (1)

250014

The First Affiliated Hospital of Shandong First Medical University, Jinan

Sponsors
All Listed Sponsors
collaborator

Nanjing Zaiming Pharmaceutical Co., Ltd.

INDUSTRY

lead

Jiangsu Simcere Pharmaceutical Co., Ltd.

INDUSTRY

NCT06654791 - Mass Balance Clinical Trial of SIM0270 | Biotech Hunter | Biotech Hunter